Vascular actions of octreotide in the portal hypertensive rat

British Journal of Pharmacology

Volumn 122, Issue 4, 1997, Pages 698-702

  Aboud, R W ^a   Connolly, C ^a   McCormick, P A ^b   Docherty, J R ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

Noradrenaline; Octreotide; Phenylephrine; Portal hypertensive rat; Rat aorta; Rat mesenteric artery; Somatostatin

Indexed keywords

ACETYLCHOLINE; NORADRENALIN; OCTREOTIDE; PHENYLEPHRINE; SOMATOSTATIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERY CONSTRICTION; ARTICLE; BLOOD FLOW; BLOOD PRESSURE; BLOOD VESSEL SHUNT; CONTROLLED STUDY; ELECTROSTIMULATION; LASER DOPPLER FLOWMETRY; MALE; MESENTERIC ARTERY; NONHUMAN; PORTAL HYPERTENSION; PRIORITY JOURNAL; RAT; VAS DEFERENS; VASCULAR ENDOTHELIUM;

ANIMALS; AORTA; BLOOD PRESSURE; HYPERTENSION, PORTAL; MALE; OCTREOTIDE; RATS; RATS, WISTAR; REGIONAL BLOOD FLOW; SPLANCHNIC CIRCULATION; SYNAPTIC TRANSMISSION; VAS DEFERENS;

EID: 0030684713     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701444     Document Type: Article

References (27)

1. 1-adrenoceptor mediating contraction of rat aorta, vas deferens and spleen. Br. J. Pharmacol., 109, 80-87.
2. + retention in portal hypertensive rats. Br. J. Gastroenterol., 104, 575-579.
3. BURROUGHS, A.K. & PANAGOU, E. (1996). Pharmacological therapy for portal hypertension: rationale and results. Seminars Gastrointest. Dis., 6, 148-164.
4. CAWLEY, T., BRESLIN, E.M., GERAGHTY, J. & DOCHERTY, J.R. (1995a). Investigations of the function of the vascular endothelium in portal hypertensive rats. Br. J. Pharmacol., 114, 791-796.
5. CAWLEY, T., BRESLIN, E., GERAGHTY, J., OSBORNE, H. & DOCHERTY, J.R. (1995b). Investigations of the function of the vascular endothelium in portal hypertensive rats. Pharmacology, 51, 381-390.
6. FENIUK, W. & HUMPHREY, P.P.A. (1994). Somatostatin-induced inhibition of neurotransmission in the mouse isolated vas deferens is resistant to pertussis toxin. Eur. J. Pharmacol., 261, 333-337.
7. FERRELL, W.R., KHOSHBATEN, A. & ANGERSON, W.J. (1990). Responses of bone and joint blood vessels in cats and rabbits to electrical stimulation of nerves supplying the knee. J. Physiol., 431, 677-687.
8. GODDEN, D.J., BAILE, E.M. & PARE, P.D. (1991). A comparison of laser Doppler flowmetry within the radio labelled microsphere reference flow technique to measure tracheal blood flow in dogs. Acta Physiol. Scand., 142, 49-57.
9. HORI, N., OKANOUE, T., SAWA, Y., ITOH, Y., MORI, T., TAKAMI, S. & KASHIMA, K. (1994). Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats. J. Gastroenterol., 29, 460-468.
10. KRAVETZ, D., BOSCH, J., ARDERIU, M.T., PIZCUETA, M.P., CASAMITJANA, R., RIVERA, F. & RODES, J. (1988). Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats. Am. J. Physiol., 254, G322-G328.
11. LIN, P.W. & SHAN, Y.S. (1994). Effect of octreotide on hemodynamics and glucagon levels in portal hypertensive rabbits. J. Formosan Med. Assoc., 93, 668-672.
12. LIN, H.C., YANG, M.C., HOU, M.C., LI, S.M., HUANG, Y.T., YU, P.C., TSAI, Y.T. & LEE, S.D. (1996). Effects of long-term administration of octreotide in portal vein-stenosed rats. Hepatology, 23, 537-543.
13. MCCORMICK, P.A., DICK, R., SIRINGO, S., WAGSTAFF, D., CHESTA, J., MCINTYRE, N. & BURROUGHS, A.K. (1990). Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension. Eur. J. Gastroenterol. Hepatol., 2, 489-492.
14. MCCORMICK, P.A., GREENSLADE, L., CHIN, J., DICK, R. & BURROUGHS, A.K. (1993a). The effect of the combination of octreotide and metoclopramide on azygos blood flow in cirrhotic patients with portal hypertension. Eur. J. Gastroenterol. Hepatol., 5, 839-843.
15. MCCORMICK, P.A., GREENSLADE, L., CHIN, J., DICK, R. & BURROUGHS, A.K. (1995). Cardiovascular effects of octreotide in patients with hepatic cirrhosis. Hepatology, 21, 1255-1260.
16. MCCORMICK, P.A., SEIFALIAN, A.M., STANSBY, G., MCGANN, G., COLLINS, P., CHIN, J., MCINTYRE, N., DICK, R. & BURROUGHS, A.K. (1993b). Superior mesenteric artery blood flow in man measured with intra-arterial Doppler catheters: effect of octreotide. J. Hepatol., 17, 20-27.
17. MAYNARD, K.I., SAVILLE, V.L. & BURNSTOCK, G. (1991). Somatostatin modulates vascular sympathetic neurotransmission in the rabbit ear artery. Eur. J. Pharmacol., 196, 125-131.
18. MULVANY, M.J. & WARSHAW, D.M. (1977). Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res., 41, 19-25.
19. POFAHL, W.E., ARDEN, W.A., BEIHN, L.D., MARTERRRE, W.F., SMITH, D.W., DERBIN, M., OREMUS, R., GROSS, D.R. & STRODEL, W.E. (1994). Small intestine microcirculatory effects of octreotide. J. Surg. Res., 56, 3345-3350.
20. SIEBER, C.C. & GROSZMANN, R.J. (1992). Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats. Gastroenterology, 103, 235-239.
21. SIEBER, C.C., LEE, F.Y. & GROSZMANN, R.J. (1996). Long-term octreotide treatment prevents vascular hyporeactivity in portal-hypertensive rats. Hepatology, 233, 1218-1223.
22. SIEBER, C.C., MOSCA, P.G. & GROSZMANN, R.J. (1992). Effect of somatostatin on mesenteric vascular resistance in normal and portal hypertensive rats. Am. J. Physiol., 262, G274-G277.
23. SIKULER, E., KRAVETZ, D. & GROSZMANN, R.J. (1985). Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am. J. Physiol., 248, G618-G625.
24. 2D-subtype. Eur. J. Pharmacol., 219, 203-210.
25. TORNEBRANDT, K., NOBIN, A. & OWMAN, C. (1987). Contractile and dilatory action of neuropeptides on isolated human mesenteric blood vessels. Peptides, 8, 251-256.
26. 1-adrenoceptor antagonists in rat aorta. Br. J. Pharmacol., 118, 299-310.
27. 1-adrenoceptor antagonists on noradrenaline-mediated contractions of rat small mesenteric artery. Br. J. Pharmacol., 118, 1308-1316.